Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease
β Scribed by Kaasinen, V.; Nagren, K.; Hietala, J.; Oikonen, V.; Vilkman, H.; Farde, L.; Halldin, C.; Rinne, J. O.
- Book ID
- 126288986
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2000
- Tongue
- English
- Weight
- 227 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0028-3878
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Huntington's disease (HD) is a neurodegenerative disorder, primarily affecting medium spiny neurones in the striatum. The density of striatal dopamine D~2~ receptors is reduced in HD but there is little known about this biomarker in brain regions outside the striatum. The primary object
Striatal dopamine D-1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early Parkinson's disease using ["CI-SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of ["F]-6-F-DOPA in